GB201620515D0

GB201620515D0 - Pharmaceutical composition

Pharmaceutical composition

Info

Publication number: GB201620515D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2016-12-02
Legal status : Ceased

Application number

GBGB1620515.5A

Current Assignee

Mexichem Fluor SA de CV

Original Assignee

Mexichem Fluor SA de CV

Priority date

2016-12-02

Filing date

2016-12-02

Publication date

2017-01-18

2016-12-02 Application filed by Mexichem Fluor SA de CV filed Critical Mexichem Fluor SA de CV

2016-12-02 Priority to GBGB1620515.5A priority Critical patent/GB201620515D0/en

2017-01-18 Publication of GB201620515D0 publication Critical patent/GB201620515D0/en

2017-09-18 Priority to AU2017328908A priority patent/AU2017328908B2/en

2017-09-18 Priority to MX2019003103A priority patent/MX2019003103A/en

2017-09-18 Priority to UAA201902773A priority patent/UA124240C2/en

2017-09-18 Priority to CN202310774818.8A priority patent/CN116898804A/en

2017-09-18 Priority to MYPI2019001314A priority patent/MY202030A/en

2017-09-18 Priority to JP2019515271A priority patent/JP6781832B2/en

2017-09-18 Priority to CN201780057285.4A priority patent/CN109789151A/en

2017-09-18 Priority to US16/334,156 priority patent/US20190388436A1/en

2017-09-18 Priority to EA201990501A priority patent/EA201990501A1/en

2017-09-18 Priority to CN202110273940.8A priority patent/CN113069417A/en

2017-09-18 Priority to EP17777636.6A priority patent/EP3515451B2/en

2017-09-18 Priority to CA3037257A priority patent/CA3037257C/en

2017-09-18 Priority to PCT/GB2017/052762 priority patent/WO2018051131A1/en

2017-09-18 Priority to BR112019005113A priority patent/BR112019005113A2/en

2017-09-18 Priority to EP19199786.5A priority patent/EP3607951A1/en

2017-09-18 Priority to GEAP201715034A priority patent/GEP20217240B/en

2017-09-18 Priority to KR1020197010383A priority patent/KR102279445B1/en

2017-09-18 Priority to NZ752434A priority patent/NZ752434B2/en

2017-09-18 Priority to EP19199776.6A priority patent/EP3610877A1/en

2017-09-18 Priority to ES17777636T priority patent/ES2841649T5/en

2017-09-18 Priority to PE2019000675A priority patent/PE20191044A1/en

2017-09-18 Priority to IL265349A priority patent/IL265349B2/en

2019-03-18 Priority to PH12019500577A priority patent/PH12019500577A1/en

2019-03-19 Priority to CONC2019/0002555A priority patent/CO2019002555A2/en

2019-09-25 Priority to US16/582,964 priority patent/US20200016175A1/en

2019-09-25 Priority to US16/582,710 priority patent/US20200016174A1/en

2020-03-11 Priority to JP2020042092A priority patent/JP6980050B2/en

2020-04-20 Priority to AU2020202651A priority patent/AU2020202651C1/en

Status Ceased legal-status Critical Current

Links

GBGB1620515.5A 2016-09-19 2016-12-02 Pharmaceutical composition Ceased GB201620515D0 (en)